[1]
“Glutamate Receptor Modulation as a Therapeutic Strategy in Neurodegenerative Diseases: Mechanisms, Pharmacological Targets, and Future Perspectives”, Int. J. Res. Clin. Hosp. Pharm., vol. 7, no. 1, pp. 01–07, Mar. 2026, doi: 10.33974/6d420p17.